China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	22.03B -6.2%
Revenue (ttm)	52.47B +3.7%
Net Income	2.00B -0.2%
EPS	2.65 -0.2%
Shares Out	754.50M
PE Ratio	11.03
Forward PE	10.50
Dividend	0.80 (2.77%)
Ex-Dividend Date	Jun 18, 2025

Volume	7,651,434
Average Volume	5,622,769
Open	28.99
Previous Close	28.91
Day's Range	28.96 - 29.40
52-Week Range	27.99 - 31.55
Beta	0.27
RSI	49.90
Earnings Date	Mar 20, 2026

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. o...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,024
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2025, SHA:600511's revenue was 52.47 billion, an increase of 3.70% compared to the previous year's 50.60 billion. Earnings were 2.00 billion, a decrease of -0.18%.